[Progress in therapy of heart failure. Mortality halved].
Schultheiss
Heinz-Peter
HP
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005544:Forecasting; D006333:Heart Failure / Q000401:mortality / Q000628:therapy*; D006801:Humans; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors